AG
BBP icon

Advisor Group’s Virtus Biotech ETF BBP Stock Holding History

Advisor Group’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13
Closed -$1K – 4951
2017
Q3 		$1K Sell
13
-37
-74% -$1.48K ﹤0.01% 4651
2017
Q2 		$2K Sell
50
-3,007
-98% -$112K ﹤0.01% 4493
2017
Q1 		$116K Buy
3,057
+2,216
+263% +$81.2K ﹤0.01% 2056
2016
Q4 		$28K Buy
841
+298
+55% +$9.75K ﹤0.01% 3007
2016
Q3 		$18K Hold
543
– – ﹤0.01% 3208
2016
Q2 		$14K Buy
+543
New +$14.3K ﹤0.01% 3283

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisor Group's BBP Position: Q4 2017 in Review

Advisor Group sold out of Virtus Biotech ETF (BBP) in Q4 2017, closing a stake of 13 shares — an estimated $1K sold.

Advisor Group first reported a position in BBP in Q2 2016 and held it in 6 quarters. The position peaked at $116K in Q1 2017. 18 funds tracked by Wall St. Rank hold BBP as of Q4 2017.

  • Advisor Group reported no remaining Virtus Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • Advisor Group sold 13 Virtus Biotech ETF shares in Q4 2017, an estimated $1K.
  • Advisor Group first reported a position in Virtus Biotech ETF in Q2 2016 and held it in 6 quarters.
  • Advisor Group's Virtus Biotech ETF position peaked at $116K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2017.

Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.